portland independent media center  
images audio video
newswire article reporting global

9.11 investigation | health

Bilderbergers/Rummy profits via avian flu fear, as anthrax hit profited Bush Carlyle Corp.

Jack up prices by creating artificial scarcity and fearmongering about a non-existent threat--or a threat that is entirely orchestrated. And who owns stock in Tamiflu? Rumsfeld and top Bilderbergers.

This is similar to the "anthrax attacks" of 9-11 that skyrocketed sales of Bush-connected Bayer monopoly on Cipro vaccine, that the Bush Administration protected and let price gouge even after the anthrax attacks. Result: Bayer made millions out of the scare in 2001 right before its monopoly runs out in 2003. The same thing was done in Gulf War One with George H. W. Bush's connection to the anthrax vaccines and other non-tested vaccines being pushed into U.S. troops--only about five years after after GHW BUSH, REAGAN, AND RUMSFELD sold Saddam anthrax bioweaponry--that then, U.S. troops were forced to buy anthrax vaccine under GHW Bush as Bush set up Gulf War One, blah, blah...ad nauseum. You get the picture. Profit in the sales of bioweaponry and intentionally seeded risks equals profits in the sales of vaccines. The "threat-vaccine two step" linked Rumsfeld and Bushes in the mid 1980s, and links them now. Is the same being done with the avian flu? Three articles below and some background on the Bush public political protections of the anthrax vaccine monopoly--that led back to Bush connected private corporations--during the October 2001 "anthrax attacks" that actually ended up being bioweaponry materials from a Ft. Detrick strain of anthrax. What goes around comes around: they will keep doing this double profit from bioweaponry scares and vaccine production over and over, until you stop them.
THEN: "Saddam, you'll get anthrax bioweaponry (and we can sell vaccine too!)"

Bilderbergers, Rumsfeld Profit from Avian Flu Scam

Global News Matrix | October 24 2005

You can't make any real money without a boogeyman, and the new "Bird Flu" hoax is the latest scam used to generate profits for pharmaceutical company insiders.

"Finally, the pieces of the puzzle start to add up," writes Dr. Joseph Mercola, author of the "Total Health Program." "President Bush sought to instill panic in this country by telling us a minimum of 200,000 people will die from the avian flu pandemic but it could be as bad as 2 million deaths in this country alone."

"This hoax is then used to justify the immediate purchase of 80 million doses of Tamiflu, a worthless drug that in no way shape or form treats the avian flu, but only decreases the amount of days one is sick and can actually contribute to the virus having more lethal mutations," Mercola continues.

"So the U.S. placed an order for 20 million doses of this worthless drug at a price of $100 per dose. That comes to a staggering $2 billion.

US Defense Secretary Donald Rumsfeld, former chairman of Gilead, the manufacturer of Tamiflu, will also make big profits, since he is a major shareholder.

Better yet, Bilderberger spokesman Etienne F. Davignon (Vice-Chairman, Suez-Tractebel) and Reagan-Bush Cabal insider former Secretary of State George P. Shultz, PhD (Distinguished Fellow, Hoover Institution, Stanford University) are also on the board of directors of Gilead. ( http://www.gilead.com/wt/sec/bod)

Another Bilderberger regular is Lodewijk J.R. de Vink, who sits on the board of Hoffman-La Roche, Gilead's partner.

In other words, the "Bird Flu" scam will generate outrageous profits for globalist-insiders like Shultz, Rumsfeld, Davignon, and de Vink.

And where did Tamiflu come from?

According to the Gilead website, "In September 1996, Gilead and F. Hoffmann-La Roche Ltd. entered into a collaborative agreement to develop and market therapies that treat and prevent viral influenza. Under the agreement, Roche received exclusive worldwide rights to Gilead's proprietary influenza neuraminidase inhibitors, including orally administered Tamiflu (oseltamivir phosphate), formerly known as GS 4104. As part of this collaboration, Gilead and Roche jointly conducted clinical development of oseltamivir phosphate, with Roche funding all research and development costs.Roche has worldwide commercial rights to Tamiflu, and Gilead receives payments from Roche for the successful completion of program milestones and royalties on product sales." ( http://www.gilead.com/wt/sec/partners)

It should be remembered that Rumsfeld loves pharmaceutical scams. It was after all Rumsfeld, as chairman of G.D. Searle, who pressured the FDA to get Aspartame approved.

The FDA blocked its approval for ten years before Rumsfeld twisted arms and broke who knows how many legs at the FDA. Now Aspartame, an artificial sweetener as ubiquitous as it is toxic, continues to poison America and the world.

So here's an advertising tagline.

Tamiflu -- It's the Bird-Flu Scam-Drug For You


Roche makes a killing

As panic spreads over avian flu, the Swiss pharmaceutical giant is accused of putting profits before people. Nick Mathiason reports

Sunday October 23, 2005
The Observer

For the obsessively guarded, conservatively dressed and unflamboyant Oeri, Hoffman and Sacher families, avian flu could be good news. Over the next two years, the heirs of Fritz Hoffman, founders of Roche, one of the world's most powerful pharmaceutical companies, and who already rank as among the world's richest families, could see their combined 10 billion fortune reach giddy heights.

Twenty members of the founding family control Roche, which industry analysts estimate will benefit from the Tamiflu drug thought to relieve the symptoms of avian flu, with extra profits of 500 million this year and 1bn next.

And since the family owns about 10 per cent of shares and crucially 50.01 per cent of voting rights, they will ensure that no outside interests seize their company and enjoy the profits - though many would like to.

As avian flu spreads from south east Asia into Europe, sparking fears of a worldwide epidemic that medical experts say could claim 50 million lives, Roche, famous as the company behind the Valium tranquilliser, appears poised to clean up. The Basel-based company is already the fastest growing drugs firm in the world with a share performance to match. Investor returns have increased 50 per cent in a year. Last week its share price reached record highs after it said third-quarter profits rose by 20 per cent to 3.9bn.

And that growth is primarily due to a drug it did not even invent. It was US biotech firm Gilead that developed Tamiflu. But nine years ago, Gilead signed a development and licensing agreement with Roche.

It is currently the subject of legal action which will be resolved in a year. Gilead claims Roche has been negligent in its manufacture of Tamiflu which has led, Gilead says, to a series of product recalls. Gilead also says Roche has failed to market the product well, which has reduced the potential revenue the drug could have made. Roche categorically refutes the allegations.

But as legal action rumbles, Roche faces other possibly more serious threats. The firm is under unrelenting pressure to increase production of Tamiflu. In the US, senator Charles Schumer has threatened legislation compulsory to license Tamiflu unless Roche allowed generic producers to boost the number of pills in circulation. [and thus lower the price, which as seen in the third article below, is hardly something that they want to do, and have stated publicly they are going to intentionally slow down production to keep the price higher.]

The senior Democratic senator for New York accused Roche of 'putting profits ahead of world safety'. He has threatened with other Republicans to introduce legislation to force Roche to relax its stranglehold on the drug.

Pressure appears to have paid off. Last Thursday, after a month of holding its position, Roche said it would talk to four generic drug manufacturers about increasing production.

But health campaigners say this is no guarantee that Roche will act. And if it does, it will delay matters as long as possible so it gets the most revenue possible before low-cost manufacturers get in on the act.

Michael Bailey, of campaigning group Oxfam says: 'This situation is absurd. A government will have to make a move because Roche seemingly can't deliver. It's a classic case of international intellectual property law not working. It seems Roche is holding on as long as possible before allowing generic companies the right to produce so it can make as much cash as possible.'

Roche says it can produce 10 million treatments each year and so far 40 governments have placed orders for Tamiflu; It says that although any government ordering a bulk supply should expect to wait a year before its order is satisfied, generic firms have to prove that they can safely manufacture Tamiflu as there are 10 complicated steps involved in its production.

While Roche is coming under intense scrutiny, the financial community is hugely supportive of the company. After all, today it is possibly Europe's best performing drug firm thanks to its investment in biotechnology companies way before other drug majors.

Much of its profits are due to its 55 per cent stake in Genentech, the US biotechnology company behind targeted cancer drugs such as MabThera and Avastin.

The company has strengthened its diagnostic division and is leading moves to tailor drugs to individual patients through the use of new technologies.

Denise Anderson, head of healthcare at Kepler Equities, says: 'They have made paradigm changing moves. They think more carefully about trends. They just started talking about healthcare IT. Right now they are in a sweetspot where successful drugs are coming on stream and I expect that to last for a good few years.'

Roche has resolutely rejected merger offers. Novartis, its bigger rival, also from Switzerland, bought a near third share in the company four years ago. It has long been thought that this was a prelude to a merger that would produce a national Swiss champion.

But the three family clans believe mergers yield no value and divert management's energy away from day-to-day business.

Though it is Fritz Gerber and Andre Hoffman who sit on Roche's board and look after the interests of the families, Roche is run by Franz Humer, who earns 5.4m - the third biggest basic salary of any publicly quoted executive in Europe.

'The Hoffman family don't need money,' says an informed insider. 'For them it's a prestige thing. They are typically Swiss. They are conservative and do things for the long term.'

But others believe that a new generation of Roche heirs will not block a merger, as the need to create a buttress against US giant Pfizer and UK rival GlaxoSmithKline deepens.

While the pharmaceuticals industry emerged in Europe with aspirin being discovered at Bayer in Germany, its centre of gravity has shifted to the US, attracted by its research scientists and lack of price controls.

But Switzerland has a reserve of scientific expertise - Swiss drugs research papers receive more citations even than US ones.

Although its expertise is not disputed, the firm has been no stranger to controversy. In the Seventies, Stanley Adams, a Roche employee, handed over documents to the European Economic Community as it was then, detailing how the company kept the price of vitamins high with the explicit collusion of its supposed rivals. But an EEC bungle identified Adams. Roche decided to prosecute and he was imprisoned under tough Swiss commercial secrecy laws. His wife then committed suicide.

Twenty years later, Roche was at it again - marshalling a price-fixing cartel in exactly the same product. It was fined more than $500m by US and EU competition regulators.

The firm has also been singled out by health campaigners for dragging its feet in allowing Aids-devastated countries in Africa to get access to vital medicines. It was one of the 39 companies that threatened to take South Africa to court to overturn its right to produce cheap copies of expensive brand-name anti-HIV drugs.

And today though it is unclear how well Roche is helping the world prepare for what could be a devastating flu epidemic.



Firms' threat to limit bird flu vaccine

London Telegraph | October 26 2005
By Rosie Murray-West

The makers of flu vaccine yesterday threatened not to produce enough bird flu vaccine to deal with an outbreak unless ministers agreed to buy more of their products.

Richard Stubbins, of the UK Vaccine Industry Group, told a House of Lords select committee that it was "unreasonable" for the Government to expect the industry to build new plants to produce enough vaccine for a pandemic then mothball them.

He called for the Government to vaccinate everyone aged over 50 and possibly children against common flu as a matter of routine. That would guarantee that the extra capacity would be used.

The industry group represents all the companies that produce flu vaccine, including the British giant Glaxosmithkline and the French company Sanofi.

A vaccine for a feared bird flu pandemic cannot be created until the strain of the virus that can pass between humans is identified.

Mr Stubbins said the Government wanted 120 million doses of vaccine as soon as it was available but there was "a lot of work to do" before companies could produce enough to meet demand.

"We have to work very closely with the Government to find ways of increasing the productivity of the industry in as short a time as possible," he said.

One way to encourage companies to do so was to increase the use of ordinary influenza vaccines.

At the moment flu vaccination is free and recommended for people over 65 and those with chronic conditions such as asthma and diabetes. Mr Stubbins said the industry was asking health officials to increase coverage until two thirds of the population was routinely vaccinated.

The Lords' science and technology committee asked Mr Stubbins and Dr Kevin Bryett, the British head of the leading vaccine company Chiron, how long it would take for a vaccine to be ready if a pandemic emerged.

They said that it could take between 10 and 11 weeks to modify a vaccine to a particular strain of the virus and sent it to the vaccine companies. It would then be four to six months before the vaccine was ready.

Mr Stubbins said the drugs industry was trying to speed up the process by creating mock-up flu vaccines so that as much work as possible was done before a pandemic emerged and the precise strain could be activated and made into a vaccine for it.

The European Commission agreed to ban the import of most live birds for a month.

Britain had made an urgent call for the ban after the death of an imported parrot at a quarantine facility in Essex blamed on the H5N1 form of the bird flu virus - although Government vets yesterday admitted a mix-up over tests.

Margaret Beckett, the Secretary of State for Environment, Food and Rural Affairs, said she was "very pleased" at the action, while it emerged at the Brussels meeting that Britain had blocked a similar ban in March.

The ban on commercial bird imports is accompanied by restrictions on imports of pet birds.

The European Union Food Safety Agency will advise people today to avoid eating raw eggs and to make sure that poultry is cooked thoroughly.

Herman Koeter, its deputy director, said: "We do not have any evidence that the bird flu virus can be transmitted through food but we can't exclude it either." [boo, boo, buy up Tamiflu]

 link to infowars.com

Bush's $7 Billion crony H5N1 Avian Flu payout: throw money at Bush pharma 02.Nov.2005 15:04


Bush's $7 Billion H5N1 Avian Flu Plan
From Patricia Doyle, PhD

Hello, Jeff - I don't see even the most basic common sense protocols in Bush's plan. H5N1 is still an ANIMAL outbreak. It would be most logical to monitor migratory birds, water fowl, etc. It would also be logical to strengthen surveillance of our borders, monitoring for exotic live bird smuggling.

Importation of poultry and poultry products should be suspended at this time to prevent importation of bird flu into the US. Preventing the flu from entering the US is the most beneficial. Migratory and wild bird/water fowl surveillance is essential now. We need to identify the problem areas where bird flu might break out.

Throwing billions into the pharmaceutical industry for a vaccine that may not - and probably WON'T - work is utterly ludicrous. The vaccine under discussion is fabricated using a 2004 Vietnamese strain of the virus. By the time the virus hits the US, it will be changed considerably, especially via recombination.

If the strain goes pandemic, it will have added the human genes that allow it to achieve sustained human-to-human transmission. It's very doubtful that the existing vaccine (which is still in clinical trials) will work. It is also of cause of concern that Bush proposes easing restricitons on the vaccine. People who were injured by the vaccine, or families of those killed by the vaccine, will have no legal recourse for suing manufacturers. It is also quite possible that there will be a mandate for vaccination.

As I said, Bird Flu is an animal outbreak at this time...but Bush's plan is not even calling for essential protocols to prevent it from entering the US via birds or swine.

I also believe there should be a moratorium on imports of swine and swine products. Indonesia did have verified H5N1 infections in swine. Although, China did not admit H5N1 in swine, there is evidence that bird flu was indeed present in swine and killed both swine and humans as a result of swine infections.

Bush's plan is not lacking the billions of dollars to be spent...but it is lacking in some very basic procedures needed to prevent infection from entering the US...and for a timely identification of H5N1 in bird and animal populations. Bush's plan definitely will be a plus for vaccine makers and the huge pharmaceutical industry.

Patricia Doyle

Bush Outlines $7.1 Billion Flu Pandemic Strategy

Program Calls For Enough Vaccine
To Protect 20 Million Americans

WASHINGTON - President Bush outlined a $7.1 billion strategy Tuesday to prepare for the danger of a pandemic influenza outbreak, saying he wanted to stockpile enough vaccine to protect 20 million Americans against the current strain of bird flu as a first wave of protection.

The president also said the United States must approve liability protection for the makers of lifesaving vaccines. He said the number of American vaccine manufacturers has plummeted because the industry has been hit with a flood of lawsuits.

Bush said no one knows when or where a deadly strain of flu will strike but "at some point we are likely to face another pandemic."

The president, in a speech at the National Institutes of Health, said the United States must be prepared to detect outbreaks anywhere in the world, stockpile vaccines and anti-viral drugs and be ready to respond at the federal, state and local levels in the event a pandemic reaches the United States.

Bush outlined a strategy that would cost $7.1 billion including:

$1.2 billion for the government to buy enough doses of the vaccine against the current strain of bird flu to protect 20 million Americans; the administration wants to have sufficient vaccine for front-line emergency personnel and at-risk populations, including military personnel.

$1 billion to stockpile more anti-viral drugs that lessen the severity of the flu symptoms.

$2.8 billion to speed the development of vaccines as new strains emerge, a process that now takes months. The goal is to have the manufacturing capability by 2010 to brew enough vaccine for every American within six months, of a pandemic's start.

$583 million for states and local governments to prepare emergency plans to respond to an outbreak.

Bush said a pandemic flu would be far more serious than the seasonal flu that makes hundreds of thousands of people sick ever year and sends people to their doctors for a flu shot. "I had mine," Bush said. Unlike seasonal flu, pandemic flu can kill people who are young and healthy as well as those who are frail and sick, he said.

In asking Congress for money to buy vaccine, Bush said the vaccine "would not be a perfect match to the pandemic flu because the pandemic strain would probably differ somewhat from the avian flu virus it grew from. But a vaccine against the current avian flu virus would likely offer some protection against a pandemic strain and possibly save many lives in the first critical months of an outbreak."

'Fair Warning'

He also said the United States was increasing stockpiles of antiviral drugs, such as Tamiflu and Relenza. Such drugs cannot prevent people from catching the flu, but they can reduce the severity of the illness when taken within 48 hours of getting sick, he said.

"At this moment there is no pandemic influenza in the United States or the world, but if history is our guide there's reason to be concerned," Bush said. "In the last century, our country and the world have been hit by three influenza pandemics, and viruses from birds contributed to all of them."

He pointed out that the 1918 pandemic [which started in U.S. military camps in the Midwest, which then rejected quarantine, and then decided to send them overseas like so many contaminated bird flocks--so the U.S. Government started the 1918 pandemic!] killed over a half million Americans and more than 20 million people across the globe. "One-third of the U.S. population was infected, and life expectancy in our country was reduced by 13 years.

"The 1918 pandemic was followed by pandemics in 1957 and 1968, which killed tens of thousands of Americans and millions across the world," Bush said.

Bird flu has been documented in Asia and has spread to Europe but has not reached the United States, the president said. "Our country has been given fair warning of this danger to our homeland and time to prepare," he said.

Bush said the cornerstone of his strategy was to develop new technologies to produce new vaccines quickly. "If a pandemic strikes, our country must have a surge capacity in place that will allow us to bring a new vaccine online quickly and manufacture enough to immunize every American against the pandemic strain," Bush said.

The principal goal of Bush's plan, Health and Human Services Secretary Michael Leavitt said, "is the capacity for every American to have a vaccine in the case of a pandemic, no matter what the virus is."

"There is no reason to believe that in the next day or two or week or month that that's going to occur," Leavitt said on CBS's "The Early Show." But he added that "we do need to be ready in case it begins to mutate into a human transmissible disease."

Stockpiling Shots

Pandemics strike when the easy-to-mutate influenza virus shifts to a strain that people have never experienced before, something that has happened three times in the last century. While it is impossible to say when the next super-flu will strike, concern is growing that the bird flu strain known as H5N1 could trigger one if it mutates to start spreading easily among people. Since 2003, at least 62 people in Southeast Asia have died from H5N1; most regularly handled poultry.

The nation's strategy starts with attempting to spot an outbreak abroad early and working to contain it before it reaches the United States.

Today, most of the world's vaccine against regular winter flu, including much of that used by Americans each flu season, is manufactured in factories in Britain and Europe.

The government already has ordered $162.5 million worth of vaccine to be made and stockpiled against the Asian bird flu, more than half to be made in a U.S. factory.

But the administration plan, to be released in more detail on Wednesday, calls for more than stockpiling shots. It will stress a new method of manufacturing flu vaccines " growing the virus to make them in easy-to-handle cell cultures instead of today's cumbersome process that uses millions of chicken eggs " as well as incentives for new U.S.-based vaccine factories to open.


Rumsfeld's growing $5 mil -$25 mil stake in Tamiflu; Schultz as well 02.Nov.2005 15:29

biowar profiteering watch


"I don't know of any biotech company that's so politically well-connected," says analyst Andrew McDonald of Think Equity Partners in San Francisco.

What's more, the federal government is emerging as one of the world's biggest customers for Tamiflu. In July, the Pentagon ordered $58 million worth of the treatment for U.S. troops around the world, and Congress is considering a multi-billion dollar purchase. Roche expects 2005 sales for Tamiflu to be about $1 billion, compared with $258 million in 2004. [around four times its previous year's profits]


Rumsfeld's growing stake in Tamiflu
Defense Secretary, ex-chairman of flu treatment rights holder, sees portfolio value growing.
October 31, 2005: 10:55 AM EST
By Nelson D. Schwartz, Fortune senior writer

NEW YORK (Fortune) - The prospect of a bird flu outbreak may be panicking people around the globe, but it's proving to be very good news for Defense Secretary Donald Rumsfeld and other politically connected investors in Gilead Sciences, the California biotech company that owns the rights to Tamiflu, the influenza remedy that's now the most-sought after drug in the world.

Rumsfeld served as Gilead (Research)'s chairman from 1997 until he joined the Bush administration in 2001, and he still holds a Gilead stake valued at between $5 million and $25 million, according to federal financial disclosures filed by Rumsfeld.

The forms don't reveal the exact number of shares Rumsfeld owns, but in the past six months fears of a pandemic and the ensuing scramble for Tamiflu have sent Gilead's stock from $35 to $47. That's made the Pentagon chief, already one of the wealthiest members of the Bush cabinet, at least $1 million richer.

Rumsfeld isn't the only political heavyweight benefiting from demand for Tamiflu, which is manufactured and marketed by Swiss pharma giant Roche. (Gilead receives a royalty from Roche equaling about 10% of sales.) Former Secretary of State George Shultz, who is on Gilead's board, has sold more than $7 million worth of Gilead since the beginning of 2005.

Another board member is the wife of former California Gov. Pete Wilson.

"I don't know of any biotech company that's so politically well-connected," says analyst Andrew McDonald of Think Equity Partners in San Francisco.

What's more, the federal government is emerging as one of the world's biggest customers for Tamiflu. In July, the Pentagon ordered $58 million worth of the treatment for U.S. troops around the world, and Congress is considering a multi-billion dollar purchase. Roche expects 2005 sales for Tamiflu to be about $1 billion, compared with $258 million in 2004.

Rumsfeld recused himself from any decisions involving Gilead when he left Gilead and became Secretary of Defense in early 2001. And late last month, notes a senior Pentagon official, Rumsfeld went even further and had the Pentagon's general counsel issue additional instructions outlining what he could and could not be involved in if there were an avian flu pandemic and the Pentagon had to respond.

As the flu issue heated up early this year, according to the Pentagon official, Rumsfeld considered unloading his entire Gilead stake and sought the advice of the Department of Justice, the SEC and the federal Office of Government Ethics.

Those agencies didn't offer an opinion so Rumsfeld consulted a private securities lawyer, who advised him that it was safer to hold on to the stock and be quite public about his recusal rather than sell and run the risk of being accused of trading on insider information, something Rumsfeld doesn't believe he possesses. So he's keeping his shares for the time being.


Roll up yer' sleeves for Rummy! 03.Nov.2005 11:51


Funny how Bush sets aside a measly 251 million for helping Asian countries locate possible sources of infection, and 7 billion goes to pharmaceutical research for vaccine programs, stockpiling, etc. Thats like telling a teen couple to prevent an unwanted pregnancy. Giving them a faulty condom, then when his girlfriend gets pregnant, they furnish the baby's room with a marble floor and a solid gold crib.
The 7 billion will soon end up in Rockefellers coffers.

Bush family wants 7 billion dollars: you? you are on your own, he says 04.Nov.2005 17:56

biofascism watch

Bush wants 7 billion for a handful of his friends, though you are on your own. As if you didn't really know that.

chicagotribune.com >> Nation/World

U.S. could leave states, towns on own in fighting flu [if the U.S. "leaves states, towns" out, what then is this U.S. thing anyway? What's left? Just the Bush family fief I guess, raking in the money and lording over death.]

By Jeremy Manier, Tribune staff reporter. Tribune news services contributed to this report
Published November 3, 2005

State and local governments should be prepared to combat a flu pandemic largely on their own, according to a new federal pandemic [non-]response plan that instructs health agencies to prepare for a crush of up to 10 million hospitalized patients.

The plan, released Wednesday by the U.S. Department of Health and Human Services, provides the first detailed look at how governments and medical experts might deal with a flu pandemic.

Coming a day after President Bush announced $7.1 billion in funding requests for antiviral medication and other measures to prepare for an outbreak, the plan outlines which groups of patients and health care workers would get priority for vaccines and other drugs.

Although no one knows if or when a pandemic will occur, the report projects that a global outbreak would kill 209,000 to 1.9 million people in the U.S. Such a crisis could overwhelm hospitals with patients, forcing communities to set up overflow sites in school gymnasiums, armories or convention centers, according to the plan.

Many state agencies have eagerly awaited the plan in recent months as a strain of avian flu spread among birds and killed dozens of people in Southeast Asia. Such a virus, to which people have no natural immunity, could spark a pandemic if it mutates into a form that can spread from one person to another.

A unique disaster

"A pandemic is unique to all other natural disasters," Health and Human Services Secretary Michael Leavitt said Wednesday. Unlike hurricanes, which are deadly but contained in scope, "It's likely that a pandemic would be occurring in a thousand or more different locations in the country," he said.

That wide reach may mean that no part of the country would have the luxury of helping other hard-hit areas, as many communities did for victims of Hurricane Katrina.

The federal plan warns that in the worst case, "thousands of communities could be countering influenza simultaneously with little or no assistance from adjacent communities, the state, or the federal government."

In Illinois, where officials are putting together the state's own pandemic response plan, the federal document offers direction on issues such as who should get vaccines first in the event of an outbreak. The only vaccine available for the Asian bird flu strain is still experimental, but the U.S. government plans to buy enough of it to cover 20 million Americans in case of an outbreak.

The groups with top priority for receiving vaccines would be workers involved in manufacture of vaccine supplies and health care workers in direct contact with ill patients. After that, vaccines would go to people whose underlying health conditions put them at high risk of death from flu, especially the elderly. The next high-priority groups include pregnant women, emergency workers and key government leaders.

"We kind of anticipated that, but it's good to be able to put that in our plan," said Daniel Lee, pandemic response coordinator for the Illinois Department of Public Health.

`No cavalry coming'

The U.S. has been slow in developing a coordinated, national plan, said Eric Holdeman, director of the King County office of emergency management in Seattle. He said the new plan's focus on self-sufficiency by local governments is sobering.

"There is no cavalry coming to the rescue," Holdeman said.

The federal plan estimates that a pandemic on a moderate scale would mean $181 billion in health costs alone, not including losses from the probable disruption in trade.

The document draws distinctions between countermeasures that might be effective in the early stages of a pandemic and responses as an outbreak becomes better established. In the first phases the goal would be containment, involving everything from isolation of infected people to targeting entire communities with antiviral drugs. Ideally, such responses could stop an outbreak in Asia or elsewhere from ever spreading to the U.S. In some cases there might be quarantines of affected communities--though the plan points out that such measures likely would work only for isolated areas or very early in an outbreak.

In lieu of quarantines, the plan calls for cities to consider calling a series of "snow days," lasting 10 days or more, during which most people would stay home from work and avoid social gatherings.

The threat of a pandemic also spurred government action Wednesday in China, where officials ordered tighter monitoring for bird flu and more aggressive vaccine research. Chinese government officials said they would create a $250 million fund for anti-bird flu measures.

U.S. Deputy Undersecretary of Agriculture Charles Lambert met with Chinese agriculture and quarantine officials in Beijing and said the two governments would increase technical cooperation and information exchanges. He urged other nations to be cautious in banning poultry imports from countries with bird flu, saying excessive steps could discourage affected nations from reporting outbreaks.



 link to www.chicagotribune.com

Precedent for Martial Law & Globalist money spinner rolled into one 10.Nov.2005 02:16

over and over

Killing Two Birds With One Tamiflu Stone

Avian Flu: Precedent for Martial Law and Globalist money spinner rolled into one

Steve Watson | November 8 2005

As the Government ratchets up the fear over a global outbreak of Bird Flu, and the public scrambles to buy up stocks of antivirals, we have continued to expose how these scare tactics are being used to set dangerous precedents for future government control of our lives.

It seems that the Neo-Con Administration is cornering every possible scenario and proposing Martial Law as the resulting solution to almost any event.

For years we have warned that the police state is coming, how Martial Law will become the norm, how ancient laws, rights and freedoms are being overturned and replaced with repressive mechanisms of control.

For years we have presented the evidence, the Army War College documents, the domestic military takeover drills, the draconian legislation, officials left right and centre calling for more centralized military control domestically. Now it seems that the globalists are ready to roll and just need the right catalyst to press ahead.

In a post 9/11 America it has become clear that should another terror attack (real or staged) occur then, according to General Tommy Franks, the Constitution will likely be discarded in favor of a military form of government.

It has also become clear that in a post Hurricane Katrina America, another large scale natural disaster (real or staged) will mean a total federal crackdown.

Now it seems that a virus outbreak such as that of Bird Flu, which we have been told over and over is inevitable, will also be remedied with a police state.

During the White House press conference of October 4th President Bush confirmed that he would attempt to impose military curfews and quarantines as well as closing Schools and restricting travel in case of a flu pandemic occurring in the United States


That came on the heels of a majority of the nation's governors rejecting the Bush administration's proposal to use active-duty military assets in providing disaster relief. Understanding this in the context of Hurricane Katrina, this means total gun confiscation and enforced evacuation at gunpoint.

The critics of the Bird Flu hype have ranged from Foreign Politicians in Russia and Spain, calling it "science fiction", to US Congressmen, including Ron Paul who stated

"To me it's so strange that the President can make these proposals and it's even plausible. When he talks about martial law dealing with some epidemic that might come later on and having forced quarantines, doing away with Posse Comitatus in order to deal with natural disasters, and hardly anybody says anything. People must be scared to death."

Paul, himself a medical doctor, agreed that the bird flu threat was empty fearmongering.

"I believe it is the President hyping this and Rumsfeld, but it has to be in combination with the people being fearful enough that they will accept the man on the white horse. My first reaction going from my political and medical background is that it's way overly hyped and to think that they have gone this far with it, without a single case in the whole country and they're willing to change the law and turn it into a military state? That is unbelievable! They're determined to have martial law."

Experts all over the world are dumbfounded by ludicrous claims that we are all about to keel over and die from Avian Flu. Gary Butcher has been an extension veterinarian at the University of Florida's College of Veterinary Medicine since 1988. He was trained as a veterinarian specializing in avian diseases, and has a Ph.D. in poultry virology. He commented:

"The emphasis of all my work has changed to dealing with this madness... Realistically, avian influenza is not a threat to people, but everywhere you go, it has turned into a circus."

Dr. Marc Siegel, a practicing internist and associate professor of medicine at the New York University School of Medicine also stated that "If anything is contagious right now, it's judgment clouded by fear."

In 2003 it was SARS, the deadly virus that caused lethal pneumonia and lung failure was sweeping the globe and it was only a matter of time before the west would succumb to its devastating wrath.

It never happened. And the pharmaceutical Companies netted huge profits.

Now we are seeing the same tactic used again with H5N1 - the dreaded bird flu.

Bush has announced a $7.1 billion strategy to prepare for the danger of a pandemic influenza outbreak, saying he wanted to stockpile enough vaccine to protect 20 million Americans and spend $1 billion on more anti-viral drugs. The World Bank is Also going to put up $1 Billion to "Fight Bird Flu". Not to mention the scores of foreign governments who are scrambling to stock up on vaccines.

So it comes as little surprise to discover that a whole host of globalists and Administration front-runners are set to personally rake millions of dollars in from the bird flu scare.

A year ago Tamiflu was known, if at all, as an obscure remedy for influenza, which doctors typically treat with bed rest and chicken soup. Today, with panic mounting over a potential bird flu pandemic, it's the most sought-after drug in the world.

Among the beneficiaries of the run on Tamiflu is Secretary of Defense Donald Rumsfeld, who was chairman of Gilead from 1997 to 2001 and owns at least $5 million of the stock, which has jumped from $35 in April to $47.

Former Secretary of State and long term Bilderberg member George Shultz, who is on Gilead's board, has also sold more than $7 million worth of Gilead in 2005.

Another Bilderberger regular is Lodewijk J.R. de Vink, who sits on the board of Hoffman-La Roche, Gilead's business partner in their venture into therapies that treat and prevent viral influenza.

Roche declared towards the end of October that they would not produce enough Tamiflu unless the government agreed to buy more of their products. This was very well politically timed as it meant just as the hype was reaching a peak it APPEARED that there was a scarcity of Tamiflu. They then reversed their statement and just produced more, which is being snapped up at an astounding rate as the hype continues.

Recall that it was Rumsfeld, as chairman of G.D. Searle, who got the FDA to approve Aspartame. The FDA relented for almost a decade but now Aspartame, an artificial sweetener and known carcinogen that has 92 known side effects including blindness and death, is in thousands of foods all over the world.

No further surprise then that according to Dr. Joseph Mercola, author of the "Total Health Program.", Tamiflu is

"... a worthless drug that in no way shape or form treats the avian flu, but only decreases the amount of days one is sick and can actually contribute to the virus having more lethal mutations,".

Tamiflu is not an influenza cure, it merely relieves symptoms. Therefore if it was prescribed in huge doses we would likely see a resistance build up and a mutation of H5N1 into a more lethal strain of influenza (That is IF it was transmittable between humans, which many experts say is unlikely to happen)

So not only will this anti-viral be more or less redundant against a flu pandemic, it may even make it worse. But do you think Rumsfeld et al care about that? Not when there's money to be made and power to be seized.


Is Bird Flu Pandemic Chicken Little Scenario?

Bush Cites Military Takeover In Case Of Flu Outbreak

Bush wants troops to enforce bird flu quarantines

Prisonplanet.com Bird Flu Archive


CDC May Sent 1918 Flu To Various US Labs 10.Nov.2005 03:20

oops, alibi for letting it escape and poof martial law..

CDC May Sent 1918 Flu To Various US Labs
By Mike Stobbe
Associated Press Writer

From Patricia Doyle, PhD

Hello Jeff - This is extremely bad news.

If this thing gets out, and, as I believe merges with H5N1 we WILL have the pandemic that the
Bush cabal seems to be 'expecting.'

How easy it will be for someone to release a chimera now and say it was an accident, or simply H5 recombining. I think that this is why all those brilliants scientists were killed off.


Patricia A. Doyle, PhD

ATLANTA - Federal scientists say they will consider requests to ship the recently recreated 1918 killer flu virus to select U.S. research labs.

There are 300 non-government research labs registered to work with deadly germs like the Spanish flu, which killed millions of people worldwide. The Centers for Disease Control and Prevention will consider requests for samples from those labs "on a case-by-case basis," CDC spokesman Von Roebuck said Wednesday.

Dangerous biological agents are routinely shipped through commercial carriers like FedEx or DHL, following government packaging, safety and security guidelines.

Last month, U.S. scientists announced they had created - from scratch - the 1918 virus. It was the first time an infectious agent behind a historic global epidemic had ever been reconstructed.

Researchers said they believed it would help them develop defenses against the threat of a future pandemic evolving from bird flu, which was found to have similar characteristics as the 1918 virus.

About 10 vials of virus were created, each containing about 10 million infectious virus particles. CDC officials said at the time the particles would be stored at a CDC facility in Atlanta, and that there were no plans to send samples off campus.

But that statement did not mean there was a policy against sending samples elsewhere, Roebuck said.

The agency's decision to consider shipping the virus outside Atlanta was first reported in the latest issue of the journal Nature. Some critics of the recreation of the virus were not pleased to learn of plans to ship the germ.

"Obviously, that contradicts what most people were led to believe when the results of the 1918 experiments were published," said Edward Hammond, director of the Sunshine Project, an Austin, Texas-based organization that advocates more control of biological weapons and biotechnology.

In addition to creating the virus, the scientists said they would place the gene-sequencing information from the new research in GenBank, a public database operated by the National Institutes of Health.

GenBank will allow some research groups to build their own virus, rather than seek samples of what the CDC had created.

"But that would be a lot of work. Wasted, duplicative work, if they (the CDC) have already made it," said Dr. Diane Griffin, chair of molecular microbiology and immunology at Johns Hopkins University's Bloomberg School of Public Health.

It's impractical to expect every influenza researcher who could learn from the 1918 virus to travel to Atlanta, said Michael Osterholm of the University of Minnesota School of Public Health.

"There's very limited lab space there," said Osterholm, director of Minnesota's Center for Infectious Disease Research & Policy.

The CDC currently has no pending requests for the virus, Roebuck said. It's unlikely many requests would come in right away, Osterholm noted.

The government requires researchers who work with such agents to use highly secure labs that meet strict training and equipment requirements. About 300 labs are registered for handling such agents, and all are located in the United States, Roebuck said.

"This (virus) is not going to go willy nilly to anyone who wants it," he said.